A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia

Research in Developmental Disabilities

Volumn 35, Issue 10, 2014, Pages 2505-2513

  Ferrari, Adriano ^a,b   Maoret, Anna Rosa ^b   Muzzini, Simonetta ^b   Alboresi, Silvia ^b   Lombardi, Francesco ^c   Sgandurra, Giuseppina ^d   Paolicelli, Paola Bruna ^d   Sicola, Elisa ^d   Cioni, Giovanni ^d,e  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Ospedale San Sebastiano   (Italy)

^d DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Botulinum toxin type A; Child hemiplegia; Orthoses; Physiotherapy; Upper limb

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; MUSCLE RELAXANT AGENT;

ARM; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FUNCTIONAL STATUS; HAND FUNCTION; HEMIPLEGIA; HUMAN; MALE; ONSET AGE; ORTHOSIS; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PLACEBO EFFECT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STRETCHING EXERCISE; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT RESPONSE; COMPLICATION; INTRAMUSCULAR DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; MUSCLE SPASTICITY; TREATMENT OUTCOME;

BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HEMIPLEGIA; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; ORTHOTIC DEVICES; PHYSICAL THERAPY MODALITIES; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 84903703066     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2014.06.001     Document Type: Article

References (28)

1. Arnould C., Penta M., Renders A., Thonnard J.L. ABILHAND-Kids: A measure of manual ability in children with cerebral palsy. Neurology 2004, 63:1045-1052.
2. Bohannon R.W., Smith M.B. Interrater reliability on a Modified Ashworth Scale of muscle spasticity. Physical Therapy 1987, 67:2006-2007.
3. Boyd R.N., Graham H.K. Botulinum toxin A in the management of children with cerebral palsy: Indication and outcome. European Journal of Neurology 1997, 4(Suppl. 2):15-22.
4. Charles J., Gordon A.M. Development of hand-arm bimanual intensive training (HABIT) for improving bimanual coordination in children with hemiplegic cerebral palsy. Developmental Medicine & Child Neurolology 2006, 48:931-936.
5. Cioni G., Sales B., Paolicelli P.B., Petacchi E., Scusa M.F., Canapicchi R. MRI and clinical characteristics of children with hemiplegic cerebral palsy. Neuropediatrics 1999, 30:249-255.
6. Eliasson A.C., Krumlinde-Sundholm L., Shaw K., Wang C. Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: An adapted model. Developmental Medicine & Child Neurology 2005, 47:266-275.
7. Esquenazi A., Novak I., Sheean G., Singer B.J., Ward A.B. International consensus statement for the use of botulinim toxin treatment in adults and children with neurological impairments-Introduction. European Journal of Neurology 2010, 17(Suppl. 2):1-8.
8. Fehlings D., Rang M., Glazier J., Steele C. Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: Child characteristics that predict a positive outcome. European Journal of Neurology 2001, 8(Suppl. 5):145-149.
9. Gilmore R., Boyd R., Sakzewski L. Upper limb activity measure for 5-6 year old children with congenital hemiplegia: A systematic review. Developmental Medicine & Child Neurolology 2008, 52(1):14-21.
10. Haley S.M., Ludlow L.H., Coster S.J. Paediatric Evaluation of Disability Inventory (PEDI): Clinical interpretation of summary scores using Rasch rating scale methodology. Physical Medicine and Rehabilitation Clinics of North America 1993, 4:529-540.
11. Hoare B.J., Wallen M.A., Imms C., Villanueva E., Rawicki H.B., Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). The Cochrane Collaboration 2010, 20(1):CD003469. 10.1002/14651858.CD003469.pub4.
12. Holmefur M., Aarts P., Hoare B., Krumlinde-Sundholm L. Test-retest and alternate forms reliability of the assisting hand assessment. Journal of Rehabilitation Medicine 2009, 1:886-891.
13. House J.H., Gwathmey F.W., Fidler M.O. A dynamic approach to the thumb-in-palm deformity in cerebral palsy. Journal of Bone & Joint Surgery 1981, 63(2):216-225.
14. Iyer L.V., Haley S.M., Watkins M.P., Dumas H.M. Establishing minimal clinically important differences for scores on the pediatric evaluation of disability inventory for inpatient rehabilitation. Physical Therapy 2003, 83:888-898.
15. Kanellopoulos A.D., Mavrogenis A.F., Mitsiokapa E.A., Panagopoulos D., Skouteli H., Vrettos S.G., et al. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children. European Journal of Physical and Rehabilitation Medicine 2009, 45:501-506.
16. Koman L.A., Mooney J.F., Smith B.P., Goodman A., Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A-toxin: Report of a preliminary, randomized, double-blind trial. Journal of Pediatric Orthopaedics 1994, 14:299-303.
17. Koman L.A., Williams R.M.M., Evans P.J., Richardson R., Naughton M.J., Passmore L., et al. Quantification of upper extremity function and range of motion in children with cerebral palsy. Developmental Medicine & Child Neurolology 2008, 50:910-917.
18. Krumlinde-Sundholm L., Eliasson A.C. Development of the assisting hand assessment: A Rasch built measure intended for children with unilateral upper limb impairment. Scandinavian Journal of Occupational Therapy 2003, 10:16-26.
19. Lukban M.B., Rosales R.L. Effectiveness of botulinum toxin A for upper limb spasticity in children with cerebral palsy: A summary of evidence. Journal of Neural Transmission 2009, 116:319-331.
20. Reeuwijk A., van Schei P.E.M., Becher J.G., Kwakkei G. Effects of botulinum toxin type A on upper limb function in children with cerebral palsy: A systematic review. Clinical Rehabilitation 2006, 20:375-387.
21. Russo R.N., Crotty M., Miller M.D., Murchland S., Flett P., Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: A single-blind, randomized, controlled trial. Pediatrics 2007, 119:1149-1158.
22. Sakzewski L., Ziviani J., Boyd R.N. Systematic review and meta-analysis of therapeutic management of upper limb dysfunction in children with congenital hemiplegia. Pediatrics 2009, 123(6):e1111-e1122.
23. Sakzewski L., Ziviani J., Boyd R.N. Efficacy of upper limb therapies for unilateral cerebral palsy: A meta-analysis. Pediatrics 2014, 133(1):e175-e204.
24. Slawek J., Bogucki A., Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: An open-label study with individualised, flexible injection regimens. Neurological Sciences 2005, 26:32-39.
25. Steenbeek D., Ketelaar M., Galama K., Gorter J.W. Goal attainment scaling in paediatric rehabilitation: A critical review of the literature. Developmental Medicine & Child Neurology 2007, 49:550-556.
26. Suresh K.P. An overview of randomization techniques: An unbiased assessment of outcome in clinical research. Journal of Human Reproductive Science 2011, 4(1):8-11.
27. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: A practical guide. Clinical Rehabilitation 2009, 23:362-370.
28. Weller C., McNeil J. CONSORT 2010 statement: Updated guidelines can improve wound care. Journal of Wound Care 2010, 19:347-353.